08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
As Benjamin Franklin once wrote, "in this world nothing can be said to be certain, except death and ...
Read More >
In this article, we follow up on our overview of going private transactions (available here) by focu...
Read More >
Governor Mills has signed into law amendments to the existing Workers’ Compensation Act that are th...
Read More >
My local school board is run by a clique who see nothing wrong that some of their children got hired...
Read More >
In Florida, when the injured employee’s attorney files a verified motion for attorney’s fees and c...
Read More >
On May 20, 2020, the Securities and Exchange Commission (SEC) amended its rules governing financial ...
Read More >